DON LYNN GIBBONS to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications DON LYNN GIBBONS has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.043
-
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling. JCO Precis Oncol. 2021 08; 5.
Score: 0.025
-
Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. 2017 03; 36(10):1384-1393.
Score: 0.018